Drug major Ranbaxy Laboratories today reported a net loss of Rs 679.80 crore for the fourth quarter ended December 31, 2008.
The drug firm had a net profit of Rs 187.80 crore in the Q4 of the previous fiscal, Ranbaxy said in a statement.
The sales rose 6.38 per cent to Rs 1,909.60 crore for the quarter under review, from Rs 1,795.10 crore in the corresponding period last fiscal.
For the financial year ended December 31, 2008, Ranbaxy reported a net loss of Rs 914.60 crore, while it had a net profit of Rs 786.60 crore in the previous year.
The total sales rose 8.34 per cent to Rs 7,250.70 crore in FY 2008, from Rs 6,692.70 crore in FY 2007.
Shares of Ranbaxy closed at Rs 186.10, down 8.89 per cent on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app